首页> 外文OA文献 >Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin
【2h】

Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin

机译:小剂量阿维A治疗迟发性糠疹IV型毛疹

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pityriasis rubra pilaris is a chronic inflammatory dermatosis of unknown etiology and great clinical variability. It has been divided into six categories. Types III, IV, and V occur in childhood and are distinguished by their clinical presentation, age of onset, and course. We report a 19-year-old male patient with a 2-week history of pruritic, scaling dermatosis of the hands, feet, elbows, and knees. He had no family history of skin disease. On physical examination, we observed circumscribed, reddish-orange, scaling plaques affecting the elbows and knees and a waxy palmoplantar keratoderma. The skin biopsy showed acanthosis, alternating orthokeratosis, parakeratosis, and follicular plugging suggestive of pityriasis rubra pilaris. The patient started treatment with oral acitretin, 25 mg every other day. The treatment was tolerated well, and after 6 months the lesions had resolved completely. Pityriasis rubra pilaris is a chronic papulosquamous disorder of unknown pathogenesis, characterized by reddish-orange scaly plaques, palmoplantar keratoderma, and keratotic follicular papules. There is still no consensus regarding the treatment, but therapeutic options include systemic retinoids, particularly acitretin in the recommended dose of 0.5 to 0.75 mg/kg/day. In our case, the patient was treated with a low-dose regimen of acitretin, which was effective and well tolerated.
机译:糠疹糠疹是一种病因不明,临床变异较大的慢性炎症性皮肤病。它分为六个类别。 III型,IV型和V型发生在儿童时期,并以其临床表现,发病年龄和病程来区分。我们报告了一名19岁的男性患者,其手,足,肘部和膝盖瘙痒,鳞屑性皮肤病病史为2周。他没有皮肤病的家族病史。体格检查时,我们观察到有外切的,橘红色的鳞屑斑块,影响了肘部和膝盖以及蜡状掌plant角化病。皮肤活检显示棘皮症,交替性角化病,角化不全和滤泡堵塞,提示糠疹为糠疹。患者开始口服口服阿维A 2隔25 mg治疗。治疗耐受良好,六个月后病灶已完全消退。糠疹糠疹(Pityriasis rubra pilaris)是一种发病机理未知的慢性丘疹性鳞状疾病,其特征是橙红色鳞片斑块,掌plant角化病和角化滤泡性丘疹。关于治疗尚无共识,但治疗选择包括全身性类维生素A,特别是阿维A酸,建议剂量为0.5至0.75 mg / kg /天。在我们的病例中,该患者接受了小剂量的阿维A酸治疗,该治疗有效且耐受良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号